Timdarpacept

DB17544InvestigationalProtein Based Therapies

IMM01 is a recombinant human signal regulatory protein α (SIRPα) IgG 1 fusion protein. IMM01 is under investigation in clinical trial NCT05140811 (A Study of IMM01 Combined With Azacitidine in...

Mechanism: Pharmacologically active on Leukocyte surface antigen CD47
Curator reviewed
Also known as: IMM-01 · IMM01

Resolves to

Compound

UNII664WQ5KSP8CAS2749520-17-8

Targets

Q08722CD47

What you can answer from here — as of July 08, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

11Clinical trialsPhase, status and sponsor resolved per trial

3+ReferencesStructured and connected to the statements they support

Which drugs share a target with Timdarpacept, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account